Literature DB >> 8810716

Asperger syndrome associated with Steinert's myotonic dystrophy.

T A Blondis1, E Cook, P Koza-Taylor, T Finn.   

Abstract

Steinert's myotonic dystrophy was diagnosed in a 10-year-old girl with Asperger syndrome. This form of myotonic dystrophy is one of a growing list of genetic diseases that can be diagnosed by analysis of a gene with trinucleotide repeats that may expand. The patient has the largest such expansion known within her pedigree. She has many of the psychological deficits that have been reported in adult-onset myotonic dystrophy. This is the first known report of an association of this disorder with Asperger syndrome. Recently Moebius syndrome has been found in association with disorders of the autistic spectrum; physicians practicing developmental medicine should now also consider Steinert's myotonic dystrophy when evaluating children with facial diplegia.

Entities:  

Mesh:

Year:  1996        PMID: 8810716     DOI: 10.1111/j.1469-8749.1996.tb15119.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  3 in total

1.  Two children with muscular dystrophies ascertained due to referral for diagnosis of autism.

Authors:  Lonnie Zwaigenbaum; Mark Tarnopolsky
Journal:  J Autism Dev Disord       Date:  2003-04

Review 2.  Psychiatric and cognitive phenotype in children and adolescents with myotonic dystrophy.

Authors:  Marie Douniol; Aurélia Jacquette; Jean-Marc Guilé; Marie-Laure Tanguy; Nathalie Angeard; Delphine Héron; Monique Plaza; David Cohen
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-06-19       Impact factor: 4.785

3.  Expanded DMPK repeats in dizygotic twins referred for diagnosis of autism versus absence of expanded DMPK repeats at screening of 330 children with autism.

Authors:  Zuzana Musova; Miroslava Hancarova; Marketa Havlovicova; Radka Pourova; Michal Hrdlicka; Josef Kraus; Marie Trkova; David Stejskal; Zdenek Sedlacek
Journal:  Neuropsychiatr Dis Treat       Date:  2016-09-19       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.